Medical Coating Market worth $15,813.6 million by 2030 - Exclusive Report by MarketsandMarkets™
Factors contributing to the medical coating market include the rising prevalence of chronic diseases, increased demand for advanced medical devices, and a growing geriatric population. Other factors driving the adoption and innovation of medical coatings include improved infection control, the growth of minimally invasive procedures, and shorter trial studies related to regulatory requirements for biocompatibility.
Browse in-depth TOC on "Medical Coating Market"
300 - Tables 50 - Figures 179 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76047356
Metals will account for the second-largest share in the medical coating market by material during the forecast period, in terms of value.
Metals are expected to hold the second-largest share of the medical coating market, by material, during the forecast period, in terms of value. Metals possess key attributes such as strength, combined with advantageous biocompatibility and durability, making them ideal for high-performance medical devices like orthopaedic implants and cardiovascular stents. Metals like silver and titanium have unique antimicrobial properties that help reduce infection risk inherently when used in implants and bearings. The growth in demand for metal coatings during this period is driven by advances in surface modification technologies and an increasing need for infection control within healthcare organizations.
Medical implants will be the second-fastest-growing application in the medical coating market during the forecast period, in terms of value.
During the forecast period, medical implants are the second fastest-growing application in the medical coating market in terms of value, mainly due to the rising prevalence of chronic diseases and the rapidly aging global population. Advances in biomaterials and coating technologies are also making implants safer and more durable with improved biocompatibility. In addition to these safety improvements, the increasing demand for orthopaedic, cardiovascular, and dental implants has driven growth across the market. Regulatory approvals and higher healthcare spending have likely supported this trend.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76047356
Europe accounts for the second-largest share in the medical coating market in terms of value.
Europe holds the second-largest share by value in the medical coating market, after North America, thanks to the region's well-developed healthcare infrastructure and large medical device manufacturing base. The region is characterized by strict regulatory environments like the EU Medical Device Regulation (MDR) and a strong focus on infection prevention, control, and AM coatings. Countries such as Germany, France, and the United Kingdom are the main demand drivers for coated devices, especially those related to cardiovascular and orthopaedic applications. Additionally, rising healthcare expenditures and the rapid expansion of wearable technologies are boosting the industry's growth across Europe.
Request Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=76047356
Key Players
Acquisitions and expansions serve as the main growth strategies used by leading companies in the market. The major global players in the medical coating industry include Hydromer (US), DSM-Firmenich (Netherlands), Surmodics (US), Biocoat Incorporated (US), AST Products Inc (US), Covalon Technologies (Canada), Freudenberg Medical (US), Harland Medical Systems, Inc (US), Merit Medical Systems (US), Applied Medical Coatings (US), PPG Industries, Inc. (US), and The Sherwin-Williams Company (US).
Get access to the latest updates on Medical Coating Companies and Medical Coating Market Size
Browse Adjacent Market: Coatings Adhesives Sealants & Elastomers Research Reports & Consulting
Related Reports:
Antimicrobial Coatings Market - Global Forecast to 2027
Thermal Spray Coatings Market - Global Forecast to 2028
Textile Coatings Market - Global Forecast to 2028
ETFE & ECTFE Coatings Market - Global Forecast to 2030
Industrial Coatings Market - Global Forecast to 2030
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@marketsandmarkets.comVisit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/medical-coating-market-worth-15-813-6-million-by-2030---exclusive-report-by-marketsandmarkets-302510468.html
SOURCE MarketsandMarkets
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Personalis to Announce Second Quarter 2025 Financial Results
FREMONT, Calif., July 22, 2025--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025. In conjunction with the release, Personalis will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights. Interested parties may access the call by dialing 877-451-6152 for domestic callers or 201-389-0879 for international callers. The webinar of the call may be accessed by visiting the Events section of the company's website at A replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company's website. About Personalis, Inc. At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California. To learn more, visit and connect with us on LinkedIn and X (Twitter). View source version on Contacts Investors: Caroline Corner investors@ 415-202-5678 Media: pr@
Yahoo
10 minutes ago
- Yahoo
East West Bancorp Reports Earnings for Second Quarter of 2025, With Record Quarterly Revenue and Net Interest Income
Total revenue (FTE), pre-tax, pre-provision income, adjusted net income, and adjusted diluted earnings per share are non-GAAP financial measures. Total revenue (FTE) represents total revenue adjusted for tax exempt interest on certain investment securities and loans. Adjusted net income and adjusted diluted earnings per share ("EPS") represent net income and diluted EPS adjusted for certain tax-effected items. See reconciliation of GAAP to non-GAAP financial measures in Table 13 of East West's detailed 2Q25 earnings release and financial tables, available at . Tangible book value per share, return on average tangible common equity, adjusted return on average tangible common equity, and tangible common equity ratio are non-GAAP financial measures. Adjusted return on average tangible common equity represents return on tangible common equity adjusted for certain tax-effected items. See reconciliation of GAAP to non-GAAP measures in Table 14 of East West's detailed 2Q25 earnings release and financial tables, available at . "Credit trends were resilient, with criticized loans and nonperforming assets both declining quarter-over-quarter. Our capital levels increased during the quarter, with East West's tangible common equity ratio growing to 10%. This position of strength will allow us to support our customers with confidence and to capitalize on market opportunities. I am also proud to report that East West was again ranked as the best performing bank above $50 billion in assets by Bank Director, marking our third consecutive year and fourth title in the past five years," Ng concluded. PASADENA, Calif., July 22, 2025 --( BUSINESS WIRE )--East West Bancorp, Inc. ("East West" or the "Company") (Nasdaq: EWBC), parent company of East West Bank, reported its financial results for the second quarter of 2025. Second quarter 2025 net income was $310 million or $2.24 per diluted share. Total loans and deposits both reached new records as of June 30, 2025, at $55.0 billion and $65.0 billion respectively. Return on average common equity was 15.4% and the total stockholders' equity to assets ratio was 10.5% for the second quarter. Book value per share and tangible book value per share 1 both grew $1.97 quarter-over-quarter. Story Continues Conference Call East West will host a conference call to discuss second quarter 2025 earnings with the public on Tuesday, July 22, 2025, at 2:00 p.m. PT/5:00 p.m. ET. The public and investment community are invited to listen as management discusses second quarter 2025 results and operating developments. The following dial-in information is provided for participation in the conference call: calls within the U.S. - (877) 506-6399; calls within Canada – (855) 669-9657; international calls – (412) 902-6699. A presentation to accompany the earnings call, a listen-only live broadcast of the call, and information to access a replay one hour after the call will all be available on the Investor Relations page of the Company's website at About East West East West provides financial services that help customers reach further and connect to new opportunities. East West Bancorp, Inc. is a public company (Nasdaq: "EWBC") with total assets of $78.2 billion as of June 30, 2025. The Company's wholly-owned subsidiary, East West Bank, is the largest independent bank headquartered in Southern California, and operates over 110 locations in the United States and Asia. The Bank's markets in the United States include California, Georgia, Illinois, Massachusetts, Nevada, New York, Texas, and Washington. For more information on East West, visit Forward-Looking Statements Certain matters set forth herein (including any exhibits hereto) contain "forward-looking statements" that are intended to be covered by the safe harbor for such statements provided by the Private Securities Litigation Reform Act of 1995. East West Bancorp, Inc. (referred to herein on an unconsolidated basis as "East West" and on a consolidated basis as the "Company," "we," "us," "our" or "EWBC") may make forward-looking statements in other documents that it files with, or furnishes to, the United States ("U.S.") Securities and Exchange Commission ("SEC") and management may make forward-looking statements to analysts, investors, media members and others. Forward-looking statements are those that do not relate to historical facts and that are based on current assumptions, beliefs, estimates, expectations and projections, many of which, by their nature, are inherently uncertain and beyond the Company's control. Forward-looking statements may relate to various matters, including the Company's financial condition, results of operations, plans, objectives, future performance, business or industry, and usually can be identified by the use of forward-looking words, such as "anticipates," "assumes," "believes," "can," "continues," "could," "estimates," "expects," "forecasts," "goal," "intends," "likely," "may," "might," "objective," "plans," "potential," "projects," "remains," "should," "target," "trend," "will," "would," or similar expressions or variations thereof, and the negative thereof, but these terms are not the exclusive means of identifying such statements. You should not place undue reliance on forward-looking statements, as they are subject to known and unknown risks and uncertainties. Factors that might cause future results to differ materially from historical performance and any forward-looking statements include, but are not limited to: changes in local, regional and global business, economic and political conditions and natural or geopolitical events; the soundness of other financial institutions and the impacts related to or resulting from bank failures and other industry volatility, including potential increased regulatory requirements, FDIC insurance premiums and assessments, and deposit withdrawals; changes in laws or the regulatory environment, including trade, monetary and fiscal policies and laws and current or potential disputes between the U.S. and the People's Republic of China, Singapore, and other countries; changes in the commercial and consumer real estate markets; changes in consumer or commercial spending, savings and borrowing habits, and patterns and behaviors; the Company's ability to compete effectively against financial institutions and other entities, including as a result of emerging technologies; the success and timing of the Company's business strategies; the Company's ability to retain key officers and employees; changes in market interest rates, competition, regulatory requirements and product mix; changes in the Company's costs of operation, compliance and expansion; disruption, failure in, or breach of, the Company's operational or security systems or infrastructure, or those of third party vendors with which the Company does business, including as a result of cyber-attacks, and the disclosure or misuse of confidential information; the adequacy of the Company's risk management framework; future credit quality and performance, including expectations regarding future credit losses and allowance levels; adverse changes to the Company's credit ratings; legal proceedings, regulatory investigations and their resolution; the Company's capital requirements and its ability to generate capital internally or raise capital on favorable terms; the impact on the Company's liquidity due to changes in the Company's ability to receive dividends from its subsidiaries; and any strategic acquisitions or divestitures and the introduction of new or expanded products and services or other events that may directly or indirectly result in a negative impact on the financial performance of the Company and its customers. For a more detailed discussion of some of the factors that might cause such differences, see the Company's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 28, 2025 under the heading Item 1A. Risk Factors. You should treat forward-looking statements as speaking only as of the date they are made and based only on information then actually known to the Company. The Company does not undertake and specifically disclaims any obligation to update or revise any forward-looking statements to reflect the occurrence of events or circumstances after the date of such statements except as required by law. View source version on Contacts For Investor Inquiries, Contact: Adrienne Atkinson Director of Investor Relations T: (626) 788-7536 E: For Media Inquiries, Contact: Angie Tang SVP - Corporate Communications T: (626) 768-6853 E:
Yahoo
10 minutes ago
- Yahoo
Blaize to Report Second Quarter 2025 Financial Results on August 14, 2025
EL DORADO HILLS, Calif., July 22, 2025--(BUSINESS WIRE)--Blaize (Nasdaq: BZAI, Nasdaq: BZAIW), a leader in programmable, energy-efficient edge AI computing, today announced it will release financial results for its second quarter ended June 30, 2025, on Thursday, August 14, 2025. Management will host a webcast that same day at 2:00 p.m. PT / 5:00 p.m. ET to discuss the company's financial performance and provide a business update. Event: Blaize Second Quarter 2025 Earnings Conference Call Date: Thursday, August 14, 2025 Time: 2:00 pm PT (5:00 pm ET) Live Webcast: A live webcast of the call can be accessed from the Events and Presentations page of the investor relations website, Replay: An archived conference call webcast will be available on Blaize's investor relations website for one year following the live call at About Blaize Blaize provides a full-stack programmable processor architecture suite and low-code/no-code software platform that enables AI processing solutions for high-performance computing at the network's edge and in the data center. Blaize solutions deliver real-time insights and decision-making capabilities at low power consumption, high efficiency, minimal size, and low cost. Headquartered in El Dorado Hills (CA), Blaize has more than 200 employees worldwide with teams in San Jose (CA) and Cary (NC), and subsidiaries in Hyderabad (India), Leeds and Kings Langley (UK), and Abu Dhabi (UAE). To learn more, visit or follow us on LinkedIn and on X at @blaizeinc. View source version on Contacts Investors ir@ Media info@
